These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15501065)

  • 1. Bridgehead modification of trihalocycloheptabenzopyridine leads to a potent farnesyl protein transferase inhibitor with improved oral metabolic stability.
    Njoroge FG; Vibulbhan B; Shi X; Strickland C; Kirschmeier P; Bishop R; Nomeir A; Girijavallabhan V
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5899-902. PubMed ID: 15501065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farnesyl protein transferase inhibitors targeting the catalytic zinc for enhanced binding.
    Njoroge FG; Vibulbhan B; Pinto P; Strickland C; Kirschmeier P; Bishop WR; Girijavallabhan V
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5877-80. PubMed ID: 15501060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent, selective, and orally bioavailable tricyclic pyridyl acetamide N-oxide inhibitors of farnesyl protein transferase with enhanced in vivo antitumor activity.
    Njoroge FG; Vibulbhan B; Pinto P; Bishop WR; Bryant MS; Nomeir AA; Lin C; Liu M; Doll RJ; Girijavallabhan V; Ganguly AK
    J Med Chem; 1998 May; 41(10):1561-7. PubMed ID: 9572881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and in vivo analysis of potent non-thiol inhibitors of farnesyl protein transferase.
    Anthony NJ; Gomez RP; Schaber MD; Mosser SD; Hamilton KA; O'Neil TJ; Koblan KS; Graham SL; Hartman GD; Shah D; Rands E; Kohl NE; Gibbs JB; Oliff AI
    J Med Chem; 1999 Aug; 42(17):3356-68. PubMed ID: 10464022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent and selective non-cysteine-containing inhibitors of protein farnesyltransferase.
    Augeri DJ; O'Connor SJ; Janowick D; Szczepankiewicz B; Sullivan G; Larsen J; Kalvin D; Cohen J; Devine E; Zhang H; Cherian S; Saeed B; Ng SC; Rosenberg S
    J Med Chem; 1998 Oct; 41(22):4288-300. PubMed ID: 9784104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farnesyl protein transferase inhibitory components of Polygonum multiflorum.
    Kwon BM; Kim SH; Baek NI; Lee SI; Kim EJ; Yang JH; Chae BS; Lee JH; Park HW; Park JS; Kim DK
    Arch Pharm Res; 2009 Apr; 32(4):495-9. PubMed ID: 19407965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Three dimensional quantitative structure-activity relationship of a series of benzocylohepatpyridine farnesyltransferase inhibitors].
    Wan SB; Yi X; Guo ZR
    Yao Xue Xue Bao; 2002 Apr; 37(4):257-62. PubMed ID: 12579819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trihalobenzocycloheptapyridine analogues of Sch 66336 as potent inhibitors of farnesyl protein transferase.
    Njoroge FG; Vibulbhan B; Pinto P; Strickland CL; Bishop WR; Kirschmeir P; Girijavallabhan V; Ganguly AK
    Bioorg Med Chem; 2003 Jan; 11(1):139-43. PubMed ID: 12467716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clavaric acid: a triterpenoid inhibitor of farnesyl-protein transferase from Clavariadelphus truncatus.
    Jayasuriya H; Silverman KC; Zink DL; Jenkins RG; Sanchez M; Pelaez F; Vilella D; Lingham RB; Singh SB
    J Nat Prod; 1998 Dec; 61(12):1568-70. PubMed ID: 9868169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and biological analyses of farnesyl-protein transferase inhibitors.
    Kohl NE; Koblan KS; Omer CA; Oliff A; Gibbs JB
    Methods Mol Biol; 1998; 84():283-91. PubMed ID: 9666457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oreganic acid, a potent inhibitor of ras farnesyl-protein transferase.
    Silverman KC; Jayasuriya H; Cascales C; Vilella D; Bills GF; Jenkins RG; Singh SB; Lingham RB
    Biochem Biophys Res Commun; 1997 Mar; 232(2):478-81. PubMed ID: 9125205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesyl transferase inhibitors: current developments and future perspectives.
    Eskens FA; Stoter G; Verweij J
    Cancer Treat Rev; 2000 Oct; 26(5):319-32. PubMed ID: 11006134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sch-66336 (sarasar) and other benzocycloheptapyridyl farnesyl protein transferase inhibitors: discovery, biology and clinical observations.
    Taveras AG; Kirschmeier P; Baum CM
    Curr Top Med Chem; 2003; 3(10):1103-14. PubMed ID: 12769711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of potent inhibitor for farnesyl pyrophosphate synthase in the mevalonate pathway.
    Gao J; Chu X; Qiu Y; Wu L; Qiao Y; Wu J; Li D
    Chem Commun (Camb); 2010 Aug; 46(29):5340-2. PubMed ID: 20544107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential.
    Tanaka R; Rubio A; Harn NK; Gernert D; Grese TA; Eishima J; Hara M; Yoda N; Ohashi R; Kuwabara T; Soga S; Akinaga S; Nara S; Kanda Y
    Bioorg Med Chem; 2007 Feb; 15(3):1363-82. PubMed ID: 17127066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic kinetic resolution of piperidine atropisomers: synthesis of a key intermediate of the farnesyl protein transferase inhibitor, SCH66336.
    Morgan B; Zaks A; Dodds DR; Liu J; Jain R; Megati S; Njoroge FG; Girijavallabhan VM
    J Org Chem; 2000 Sep; 65(18):5451-9. PubMed ID: 10970281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent and selective farnesyl transferase inhibitors.
    Millet R; Domarkas J; Houssin R; Gilleron P; Goossens JF; Chavatte P; Logé C; Pommery N; Pommery J; Hénichart JP
    J Med Chem; 2004 Dec; 47(27):6812-20. PubMed ID: 15615530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current progress on farnesyl protein transferase inhibitors.
    Singh SB; Lingham RB
    Curr Opin Drug Discov Devel; 2002 Mar; 5(2):225-44. PubMed ID: 11926129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the complex of a trifluoromethyl-substituted shikimate-based bisubstrate inhibitor and 5-enolpyruvylshikimate-3-phosphate synthase by REDOR NMR.
    McDowell LM; Studelska DR; Poliks B; O'Connor RD; Schaefer J
    Biochemistry; 2004 Jun; 43(21):6606-11. PubMed ID: 15157093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric studies of potent inhibitors of farnesyl protein transferase--detection of pentameric noncovalent complexes.
    Mirza UA; Chen G; Liu YH; Doll RJ; Girijavallabhan VM; Ganguly AK; Pramanik BN
    J Mass Spectrom; 2008 Oct; 43(10):1393-401. PubMed ID: 18438977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.